Clinical Trial Update: PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a PSA-based vaccine plus radiotherapy for localized prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• PSA-based vaccine (Prostate-specific antigen vaccine)
• Radiotherapy

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Prostate Cancer, Prostate Neoplasm | Phase 2 | Status: COMPLETED